- Posts by Erin C. Villaseñor
Of CounselErin Villaseñor represents clients in all aspects of commercial and intellectual property litigation. She has extensive experience in patent, copyright, and trade secret cases and matters involving complex technologies ...
Just five years ago, on May 11, 2016, President Obama signed the Defend Trade Secrets Act (the “DTSA”). This important legislation created a new, federal civil cause of action for trade secret misappropriation. The DTSA came on the heels of the 2011 America Invents Act (the “AIA”)—the most significant ...
More
The COVID-19 pandemic has been a catalyst for medical technology innovation, especially the Internet of Medical Things (IoMT). IoMT generally refers to the use of network and cloud technologies to connect medical equipment and devices with healthcare information technology systems. With IoMT technology ...
More
RSS Feed
Follow us on Twitter
Follow us on LinkedInRecent Posts
- Short Order, Big Change Brought to Patent Docket of Western District of Texas
- NFTs: The Future of Managing Patent Assets?
- There Won’t Always Be a Stark in Delaware
- Significant Current Issues in Patent Litigation: What to Watch in 2022
- How the Shift to a Permanent Remote Workforce Can Impact Venue for Patent Infringement Lawsuits
- What’s Really Going on with Fintiv at the Patent Trial and Appeal Board?
- United States v. Arthrex: Power given to PTAB Patent Judges “Incompatible” with their Appointment
- Anticipating President Biden’s Intellectual Property Policy in an Historical Context
- Patent and Trade Secret Protection of Inventions: 5 Things to Remember on the 5th Anniversary of the Defend Trade Secrets Act
- To Stay or Not to Stay: the Impact of IPRs on Patent Litigation